Articles By Keyword

. "Semiparametric inference for a 2-stage outcome-auxiliary-dependent sampling design with continuous outcome.." Biostatistics. 2011;12(3):521-34. Pub Med
. "Bayesian inference for network meta-regression using multivariate random effects with applications to cholesterol lowering drugs.." Biostatistics. 2019;20(3):499-516. Pub Med
. "Incorporating higher-order representative features improves prediction in network-based cancer prognosis analysis.." BMC Med Genomics. 2011;4():5. Pub Med
. "Tests of trend between disease outcomes and ordinal covariates discretized from underlying continuous variables: simulation studies and applications to NHANES 2007-2008.." BMC Med Res Methodol. 2019;19(1):2. Pub Med
. "Statistical considerations for analysis of microarray experiments.." Clin Transl Sci. 2011;4(6):466-77. Pub Med
. "Statistical issues for design and analysis of single-arm multi-stage phase II cancer clinical trials.." Contemp Clin Trials. 2015;42():9-17. Pub Med
. "Bayesian clinical trial design using Markov models with applications to autoimmune disease.." Contemp Clin Trials. 2017;63():73-83. Pub Med
. "Meta-analysis of genome-wide association studies: No efficiency gain in using individual participant data.." Genet Epidemiol. 2010;34(1):60-6. Pub Med
. "Multivariate phenotype association analysis by marker-set kernel machine regression.." Genet Epidemiol. 2012;36(7):686-95. Pub Med
. "Reexamining dis/similarity-based tests for rare-variant association with case-control samples.." Genetics. 2018;209(1):105-113. Pub Med
. "I-Boost: An integrative boosting approach for predicting survival time with multiple genomics platforms.." Genome Biol. 2019;20(1):52. Pub Med
. "A longitudinal functional analysis framework for analysis of white matter tract statistics.." Inf Process Med Imaging. 2013;23():220-31. Pub Med
. "Modelling recurrent events: A tutorial for analysis in epidemiology.." Int J Epidemiol. 2015;44(1):324-33. Pub Med
. "Statistical design of noninferiority multiple region clinical trials to assess global and consistent treatment effects.." J Biopharm Stat. 2017;27(6):933-944. Pub Med
. "Biomarker threshold adaptive designs for survival endpoints.." J Biopharm Stat. 2018;28(6):1038-1054. Pub Med
. "Statistical issues and advances in cancer precision medicine research.." J Biopharm Stat. 2018;28(2):215-216. Pub Med
. "Phase II cancer clinical trials with heterogeneous patient populations.." J Biopharm Stat. 2012;22(2):312-28. Pub Med
. "Statistical methods for conditional survival analysis. ." J Biopharm Stat. 2018;28(5):927-938. Pub Med
. "The use of Bayesian hierarchical models for adaptive randomization in biomarker-driven phase II studies.." J Biopharm Stat. 2015;25(1):66-88. Pub Med
. "Medical records-based postmarketing safety evaluation of rare events with uncertain status.." J Biopharm Stat. 2013;23(4):744-55. Pub Med
. "Basic concepts and methods for joint models of longitudinal and survival data.." J Clin Oncol. 2010;28(16):2796-801. Pub Med
. "Semiparametric estimation of treatment effect with time-lagged response in the presence of informative censoring.." Lifetime Data Anal. 2011;17(4):566-93. Pub Med
. "Efficient estimation of the distribution of time to composite endpoint when some endpoints are only partially observed.." Lifetime Data Anal. 2013;19(4):513-46. Pub Med
. "Optimal treatment regimes for survival endpoints using a locally-efficient doubly-robust estimator from a classification perspective.." Lifetime Data Anal. 2017;23(4):585-604. Pub Med
. "Bayesian gamma frailty models for survival data with semi-competing risks and treatment switching.." Lifetime Data Anal. 2014;20(1):76-105. Pub Med
. "Marginal hazard regression for correlated failure time data with auxiliary covariates.." Lifetime Data Anal. 2012;18(1):116-38. Pub Med
. "Semiparametric additive marginal regression models for multiple type recurrent events.." Lifetime Data Anal. 2012;18(4):504-27. Pub Med
. "Proportional exponentiated link transformed hazards (ELTH) models for discrete time survival data with application.." Lifetime Data Anal. 2016;22(1):38-62. Pub Med
. "Predicting risk of chemotherapy-induced severe neutropenia: A pooled analysis in individual patients data with advanced lung cancer.." Lung Cancer. 2020;141():14-20. Pub Med
. "Use of historical control data for assessing treatment effects in clinical trials.." Pharm Stat. 2014;13(1):41-54. Pub Med
. "A novel test to compare two treatments based on endpoints involving both nonfatal and fatal events.." Pharm Stat. 2015;14(4):273-83. Pub Med
. "Tximeta: Reference sequence checksums for provenance identification in RNA-seq.." PLoS Comput Biol. 2020;16(2):e1007664. Pub Med
. "Ten simple rules for effective statistical practice.." PLoS Comput Biol. 2016;12(6):e1004961. Pub Med
. "Block-diagonal discriminant analysis and its bias-corrected rules.." Stat Appl Genet Mol Biol. 2013;12(3):347-59. Pub Med
. "Auxiliary variable-enriched biomarker-stratified design.." Stat Med. 2018;37(30):4610-4635. Pub Med
. "On optimal treatment regimes selection for mean survival time.." Stat Med. 2015;34(7):1169-84. Pub Med
. "Bayesian inference for multivariate meta-analysis Box-Cox transformation models for individual patient data with applications to evaluation of cholesterol-lowering drugs.." Stat Med. 2013;32(23):3972-90. Pub Med
. "Comparison of adaptive treatment strategies based on longitudinal outcomes in sequential multiple assignment randomized trials.." Stat Med. 2017;36(3):403-415. Pub Med
. "Independence screening for high dimensional nonlinear additive ODE models with applications to dynamic gene regulatory networks.." Stat Med. 2018;37(17):2630-2644. Pub Med
. "Assessing model fit in joint models of longitudinal and survival data with applications to cancer clinical trials.." Stat Med. 2014;33(27):4715-33. Pub Med
. "Hypothesis testing for two-stage designs with over or under enrollment.." Stat Med. 2015;34(16):2417-26. Pub Med
. "Identifying optimal dosage regimes under safety constraints: An application to long term opioid treatment of chronic pain.." Stat Med. 2018;37(9):1407-1418. Pub Med
. "Joint modeling of survival and longitudinal non-survival data: current methods and issues. Report of the DIA Bayesian joint modeling working group.." Stat Med. 2015;34(14):2181-95. Pub Med
. "Statistical inferences for data from studies conducted with an aggregated multivariate outcome-dependent sample design.." Stat Med. 2017;36(6):985-997. Pub Med
. "On model selections for repeated measurement data in clinical studies.." Stat Med. 2015;34(10):1621-33. Pub Med
. "Multiple testing of treatment-effect-modifying biomarkers in a randomized clinical trial with a survival endpoint.." Stat Med. 2011;30(13):1502-18. Pub Med
. "Sample size calculation for studies with grouped survival data.." Stat Med. 2018;37(27):3904-3917. Pub Med
. "A model-based conditional power assessment for decision making in randomized controlled trial studies. ." Stat Med. 2017;36(30):4765-4776. Pub Med
. "Bayesian design of a survival trial with a cured fraction using historical data.." Stat Med. 2018;37(26):3814-3831. Pub Med
. "Secondary outcome analysis for data from an outcome-dependent sampling design.." Stat Med. 2018;37(15):2321-2337. Pub Med